Company
cgen.com
Compugen is a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery
Also known as Compugen, Compugen Ltd.
- Status
- Operatingas of 2026-09-21
- Business model
- B2B
- Headquarters
- Holon, Israel
- Legal name
- Compugen Ltd.
- cgen.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Compugen is a clinical-stage drug discovery and development company utilizing a broadly applicable, predictive computational discovery platform to identify novel drug targets and new biological pathways and develop therapeutics in the field of cancer immunotherapy.
Funding snapshot
- Total raised
- $32MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $20M2021-11-10
Funding rounds
- Round, 2021
- $20M2021-11-10, SEC form D sold, 1 investor
- Round, 2018
- $12M2018-10-11, SEC form D sold, 1 investor
Loading relationship preview